<img height="1" width="1" style="display:none" src="https://q.quora.com/_/ad/fddcdc9dc8954bf7bdefaa9d33414665/pixel?tag=ViewContent&amp;noscript=1">

Dr. Anthony Fauci's Publications Reveal his Expertise

July 14, 2020

Dr. Anthony Fauci has been in the news since his appointment to the White House Coronavirus Task Force in January 2020. While he is widely known as an immunologist and has served as director of the National Institute of Allergy and Infectious Disease since 1984, it is often difficult to effectively capture the scope and scale of Dr. Fauci's scientific expertise. 

Using ResoluteAI's Foundation database, in July 2020 we searched for all publications for which Dr. Fauci was listed as an author. We then used the analytics tools to render a diagram that automatically categorized his 286 publications into areas of expertise, giving us a quick, accurate, and efficient snapshot of Dr. Fauci's contributions to the medical community:

Anthony Fauci Publications

In 2020, Dr. Fauci was mentioned nearly 48,000 times in various news outlets in relation to COVID-19. He was also mentioned in a number of other areas, including immunology and biocides.
resoluteai sankey diagram showing publications dr.fauci was mentioned in for 2020As of March 9, 2021, Dr. Fauci has been mentioned in the news over 2,200 times in relation to COVID-19. Is he is on his way to net more mentions than last year?

Interested in learning more about what you can discover with ResoluteAI?

Let's talk


ResoluteAI is the research platform for science. Foundation lets commercial science enterprises search aggregated scientific, regulatory, and business databases simultaneously. Nebula is our enterprise search tool for science. Combined with our interactive analytics and downloadable visualizations, ResoluteAI helps make connections that lead to breakthrough discoveries. Used in R&D, medical affairs, post market surveillance, and pharmacovigilance by scientific organizations around the world, ResoluteAI won the BCS Search Industry Award for Most Promising Start-Up in 2021.